Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elscint was a pioneering Israeli medical imaging company that specialized in the development and manufacture of advanced diagnostic equipment, including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Nuclear Medicine systems. Founded in 1969, it became a global leader in the medical technology sector and was the first Israeli company to list on the NASDAQ. During the late 1990s, the company's core business units were sold to major industry players GE Healthcare and Philips (formerly Picker). Today, the Elscint brand is primarily recognized for its historical contributions to medical imaging innovation and its role in establishing the Israeli high-tech industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elscint.